Trending Now
Cellect Biotechnology Ltd – ADR (NASDAQ:APOP) Receives an Approval of a...
Every successful medicinal activity requires mass production of quality stem cells. This is what avails regenerative medicine to the public the need occasioned the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Stability and Dividend Potential of Healthcare Stocks (GILD,BMY,DHR)
Recent market volatility has shifted investor focus on on stability and dividend potential of healthcare stocks. The focus is on pharmaceutical and...
MAKE IT MODERN
LATEST REVIEWS
Cassava Sciences (SAVA stock) Soars on Executive Chairman’s Open Letter
Today was a thrilling day for investors in Cassava Sciences, Inc. (NASDAQ: SAVA). The company's stock surged by an impressive 27.28%, closing...
MAKE IT MODERN
PERFORMANCE TRAINING
Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LLY,...
With the spotlight firmly on Covid variants, it’s easy to lose sight of what will probably be the most important segment of...
Altimmune Inc (NASDAQ:ALT) Says the Multiple Dose Toxicity and Toxicokinetic Studies of ALT-801 Were...
Altimmune Inc (NASDAQ:ALT) is continuously pursuing the development of immune-modulating therapies, the primary focus being treatments for liver disease. In its diverse pipeline, the...
Silverback Therapeutics Inc. (NASDAQ: SBTX) Reports Phase 1/1b SBT6050 Study Data In Combination With...
Silverback Therapeutics Inc. (NASDAQ: SBTX) has presented interim results from its Phase1/1b SBT6050 clinical study as a monotherapy and combined with pembrolizumab in metastatic...
The Second Wave Portfolio (DGX, RXMD, APT)
The second wave is already here, or it’s coming. The bridge to a vaccine will have to be lengthened a bit. If you live...
BioNTech SE (NASDAQ: BNTX) To Discuss mRNA Technology Behind COVD-19 Vaccine At Disrupt 2021
One tech company that had had a considerable impact in the past decade is mRNA therapeutics pioneer BioNTech SE (NASDAQ: BNTX). The mRNA technology...
MAKE IT MODERN
